Matches in SCALES for { <scales/DocketEntry/ilnd;;1:05-cv-01490_de535> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- ilnd;;1:05-cv-01490_de535 RegisterActionDate "2006-12-20" @default.
- ilnd;;1:05-cv-01490_de535 RegisterActionDescriptionText "MINUTE entry before Judge Geraldine Soat Brown :Motion hearing held. For the reasons stated on the record, defendant's second motion to compel 486 is granted in part and denied in part. Andrx' motion is denied insofar as it seeks production of documents relating to the negotiation of Teva and Ranbaxy settlements. The motion is granted as follows: 1) Abbott shall produce by noon on 12/22/06 the following documents: a) Docket number 421, Teva's emergency motion, which will be produced in its entirety, but without Exhibit A, and the Declaration of David Marshal, docket number 422. Those documents shall be held as "Highly Confidential" pursuant to the Protective Order; b) The following portions of the settlement agreements with Teva and Ranbaxy: In both settlement agreements, the introductory paragraphs and the recitals; In Ranbaxy's settlement agreement paragraphs 4.1 and 4.2; and in Teva's settlement agreement paragraphs 4.1, 4.3 and 4.2 except for the second and third sentences of 4.2, which may be redacted. The settlement agreement portions will be held "outside counsel's eyes only" 2) No later than 01/05/06 Abbott must produce any documents subsequent to September 2005 that contain or constitute communications between Abbott and Dava regarding the possible licensing of Abbott's BIAXIN XL. Those documents will be held as "Highly Confidential" pursuant to the Protective Order. Notice mailed by judge's staff (ntf, ) (Entered: 12/20/2006)" @default.
- ilnd;;1:05-cv-01490_de535 AdministrativeID "516" @default.
- ilnd;;1:05-cv-01490_de535 hasReferenceToOtherEntry ilnd;;1:05-cv-01490_de502 @default.